Stallion India Fluorochemicals Limited is set to launch its Initial Public Offering (IPO) on January 16, 2025, aiming to raise ₹199.45 crore. Below is a detailed overview of the IPO, including key dates, financial details, Grey Market Premium (GMP) insights, and an analysis of the company’s business model.
IPO Details:
- Issue Period: January 16, 2025 – January 20, 2025
- Issue Size: ₹199.45 crore
- Fresh Issue: ₹160.73 crore
- Offer for Sale: ₹38.72 crore
- Price Band: ₹85 – ₹90 per share
- Face Value: ₹10 per share
- Market Lot: 165 shares
- Listing Exchanges: BSE and NSE
- Listing Date: January 23, 2025
Important Dates:
- Basis of Allotment: January 21, 2025
- Refunds Initiation: January 22, 2025
- Credit to Demat Accounts: January 22, 2025
Grey Market Premium (GMP):
As of January 15, 2025, the GMP for Stallion India Fluorochemicals IPO is approximately ₹33. This suggests an expected listing price of around ₹123 per share, indicating a potential listing gain of about 36.67% over the upper price band of ₹90.
Business Overview:
Incorporated on September 5, 2002, and based in Mumbai, Stallion India Fluorochemicals operates in the fluorochemicals sector, focusing on:
- Manufacturing and Distribution: Producing refrigerant and industrial gases.
- Product Offerings: Selling pre-filled cans, small cylinders, and related products.
- Custom Solutions: Developing custom gas blends for diverse industrial applications.
Financial Highlights:
While specific financial details are limited in the provided sources, the company’s decision to raise capital through a combination of fresh issues and offers for sale indicates a strategy to fund expansion and provide partial exits to existing shareholders.
Investment Considerations:
- Positive Indicators:
- GMP Trends: A positive GMP suggests favorable market sentiment.
- Industry Position: Operating in the fluorochemicals sector, which has significant industrial applications.
- Risks:
- Market Volatility: GMP can fluctuate, and is not always a reliable indicator of listing performance.
- Limited Financial Data: Potential investors should seek comprehensive financial information to assess the company’s profitability and growth prospects.
Conclusion:
Stallion India Fluorochemicals’ IPO presents an opportunity to invest in a company within the fluorochemicals industry. The current GMP indicates potential listing gains; however, investors should conduct thorough due diligence, considering both the company’s business model and prevailing market conditions, before making investment decisions.
